Pricing Log in Create free account

Anavex Life Sciences Corp. (AVXL) vs Cue Biopharma, Inc. (CUE)

Anavex Life Sciences Corp. and Cue Biopharma, Inc. are both Biotechnology companies. Anavex Life Sciences Corp. and Cue Biopharma, Inc. are of similar size ($137.2M and $135.6M). Anavex Life Sciences Corp. has the higher net margin (0.00% vs −435.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Anavex Life Sciences Corp. leads on 9 and Cue Biopharma, Inc. on 2.

Valuation

Metric AVXL CUE Biotechnology median
P/E n/m n/m 8.42
P/S n/m 3.14 10.01
P/B 1.22 51.25 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales n/m 2.73 9.41
Earnings yield (10.14%) (144.73%) (31.85%)
Free cash flow yield (21.35%) (42.34%) (24.58%)

Profitability

Metric AVXL CUE Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (262.03%) 0.00%
Net margin 0.00% (435.83%) 0.00%
Free cash flow margin 0.00% (133.13%) 0.00%
Return on equity (12.80%) (1,603.48%) (56.36%)
Return on assets (11.70%) (459.60%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVXL CUE Biotechnology median
Revenue growth (TTM) — 354.37% 6.02%
EPS growth (last fiscal year) (3.85%) 61.11% 30.26%
Revenue growth, 5-year CAGR — 54.16% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVXL CUE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.62 1.25 4.72
Net debt to EBITDA 2.00 1.10 0.96

Dividend

Metric AVXL CUE Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric AVXL CUE Biotechnology median
Market cap 137.19m 135.63m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack